Try a new search

Format these results:

Searched for:

in-biosketch:true

person:nossee01

Total Results:

165


Objective motion-based performance assessment in STA-MCA microanastomosis: a postprocedural debriefing platform

Kariv, Saar; Grin, Eric A; Gutstadt, Eleanor; Ryoo, James S; Mathew, Cristian; Campbell, Taylor; Raz, Eytan; Shapiro, Maksim; Chung, Charlotte Y; Sharashidze, Vera; Riina, Howard A; Rutledge, Caleb; Baranoski, Jacob F; Nossek, Erez
OBJECTIVE:The aim of this study was to develop and demonstrate a postprocedural motion analysis platform capable of objectively quantifying intraoperative surgeon micromovements to facilitate evidence-based self-debriefing in suturing superficial temporal artery-middle cerebral artery microanastomosis. METHODS:The authors analyzed microscope-recorded microanastomoses performed by a cerebrovascular neurosurgeon. Seven suture-placement clips were extracted from operative videos. A computer vision tracking pipeline was implemented in Python using OpenCV to track the needle holder position across the video clips. Four motion metrics were computed for each video clip: absolute error, velocity, acceleration, and jerk. A unified reference distribution was constructed from all clips, and 95th percentile thresholds were defined for each metric. The metrics were displayed as dynamic synchronized plots alongside the corresponding video. Spectral decomposition of the position signal was performed to generate time-frequency representations, and average power in the 6- to 8-Hz band was computed as a quantitative tremor measure. To demonstrate reliable longitudinal performance tracking, the authors applied their platform to 8 recorded procedures between 2023 and 2026 and plotted the mean jerk per suture over time. RESULTS:Reliable tracking was achieved across 92.09% of analyzed footage. Two-dimensional trajectories were reconstructed for a total of 13,183 analyzed frames encompassing 219.82 seconds of suture-placement video (7 clips). Jerk analysis revealed multiple segments exceeding the 95th percentile threshold, flagging moments for surgical review. Time-frequency analysis revealed transient broadband power bursts and 2 persistent spectral bands (6-8 Hz and < 4 Hz). Tremor intensity analysis in the 6- to 8-Hz range revealed temporal tremor fluctuations, a finding undetectable by other metrics. Longitudinal performance tracking was feasible and demonstrated a stable jerk profile, consistent with expert-level performance. CONCLUSIONS:A motion-based postprocedural debriefing platform for the performance of microanastomosis is technically feasible and capable of generating objective, quantitative performance metrics from standard operative video. Unlike prior work focused on expert-novice differentiation, this platform was designed to support individualized self-assessment and reflective practice for surgeons at any experience level. Future work should validate the platform prospectively and correlate motion-based metrics with clinical outcomes.
PMID: 42967343
ISSN: 1092-0684
CID: 6075419

Admission functional status and selection for surgical evacuation as an adjunct to middle meningeal artery embolisation for chronic subdural haematoma: the MESH registry

Essibayi, Muhammed Amir; DeMessie, Bluyé; Salim, Hamza; Karandish, Alireza; Khatri, Deepak; Haranhalli, Neil; Baker, Amanda; Zampolin, Richard; Brook, Allan L; Lee, Seon-Kyu; Adeeb, Nimer; Li, Yan Lin; Lakhani, Dhairya A; Simonato, Davide; Alsalama, Abdulrhman; Ortega, Diego Alejandro; Cancelliere, Nicole M; Diestro, Jose Danilo Bengzon; Carnevale, Joseph Anthony; Schreiber, Craig; Orscelik, Atakan; Abecassis, Zack; Raub, Spencer; Sioutas, Georgios; Salsano, Giancarlo; Kvint, Svetlana; Falzon, Andrew; Cantrell, Vance; Holliday, Brian; Abaricia, Jefferson O; Maleknia, Pedram; Cruz-Criollo, Leonardo; Schimmel, Samantha; Musmar, Basel; Alexander, Matthew; Rios-Zermeno, Jorge; Koul, Prateeka; Aljuboori, Ahmed; Vollherbst, Dominik F; Gajski, Domagoj; Cooper, Jared; Ezzeldin, Mohamad; Ogilvy, Christopher S; Abo Kasem, Rahim; Al Kasab, Sami; Spiotta, Alejandro M; Al-Mufti, Fawaz; Kalousek, Vladimir; Möhlenbruch, Markus A; Scarcia, Luca; Tang, Si Zhao; Sporns, Peter B; Gopinathan, Anil; Regenhardt, Robert; Blackburn, Spiros; Schirmer, Clemens; Huynh, Thien J; Tawk, Rabih; Settecase, Fabio; Tjoumakaris, Stavropoula I; Jabbour, Pascal; Vakharia, Kunal; Zanaty, Mario; Ortega-Gutierrez, Santiago; Jones, Jesse; Colasurdo, Marco; Nasser, Hussein; Sundararajan, Sri Hari; Mosimann, Pascal J; Nossek, Erez; Raz, Eytan; Castellan, Lucio; Del Sette, Bruno; Alaraj, Ali; Michelozzi, Caterina; Saraceno, Davide; Panni, Pietro; Srinivasan, Visish; Burkhardt, Jan-Karl; Marnat, Gaultier; Mario Santini, Pietro; Levitt, Michael; Lanzino, Giuseppe; Brinjikji, Waleed; Knopman, Jared; Kass-Hout, Tareq; Spears, Julian; Marotta, Thomas; Mendes Pereira, Vitor; Fuschi, Maurizio; Dmytriw, Adam A; Altschul, David; ,
PMID: 42901760
ISSN: 1468-330x
CID: 6074877

Machine Learning Prediction of Treatment Failure After Middle Meningeal Artery Embolization for Subdural Hematoma

DeMessie, Bluyé; Essibayi, Muhammed Amir; Salim, Hamza Adel; Karandish, Alireza; Azzam, Ahmed Y; Khatri, Deepak; Haranhalli, Neil; Baker, Amanda; Zampolin, Richard; Brook, Allan L; Lee, Seon-Kyu; Adeeb, Nimer; Lakhani, Dhairya A; Grist, James; Zaccagna, Fulvio; Li, Yan-Lin; Simonato, Davide; Ortega, Diego Alejandro; Cancelliere, Nicole; Diestro, Jose Danilo; Carnevale, Joseph; Schreiber, Craig; Orscelik, Atakan; Abecassis, Zachary; Raub, Spencer; Sioutas, Georgios S; Alsalama, Abdulrhman; Pearce, Clairice; Salsano, Giancarlo; Abo Kasem, Rahim; Kvint, Svetlana; Falzon, Andrew; Cantrell, Vance; Holliday, Brian; Abaricia, Jefferson O; Maleknia, Pedram D; Cruz-Criollo, Leonardo; Schimmel, Samantha; Musmar, Basel; Alexander, Matthew; Zermeno, Jorge Rios; Koul, Prateeka; Aljuboori, Ahmed; Vollherbst, Dominik F; Gajski, Domagoj; Cooper, Jared; Alwakaa, Omar; Ezzeldin, Mohamad; Ogilvy, Christopher S; Al-Mufti, Fawaz; Kalousek, Vladimir; Möhlenbruch, Markus A; Scarcia, Luca; Wroe, William W; Zeineddine, Hussein A; Zhao, Tang Si; Sporns, Peter B; Gopinathan, Anil; Regenhardt, Robert W; Blackburn, Spiros L; Schirmer, Clemens M; Huynh, Thien; Tawk, Rabih G; Settecase, Fabio; Tjoumakaris, Stavropoula; Jabbour, Pascal; Vakharia, Kunal; Zanaty, Mario; Ortega-Gutierrez, Santiago; Jones, Jesse G; Colasurdo, Marco; Nasser, Hussein H; Sundararajan, Sri Hari; Mosimann, Pascal J; Nossek, Erez; Raz, Eytan; Al Kasab, Sami; Spiotta, Alejandro M; Castellan, Lucio; Del Sette, Bruno; Alaraj, Ali; Michelozzi, Caterina; Saraceno, Davide; Panni, Pietro; Srinivasan, Visish M; Burkhardt, Jan-Karl; Marnat, Gaultier; Santini, Pietro Mario; Levitt, Michael R; Lanzino, Giuseppe; Brinjikji, Waleed; Knopman, Jared; Kass-Hout, Tareq; Spears, Julian; Marotta, Thomas; Pereira, Vitor Mendes; Fuschi, Maurizio; Dmytriw, Adam A; Altschul, David J; ,
BACKGROUND AND OBJECTIVES/OBJECTIVE:Middle meningeal artery embolization (MMAE) is effective for chronic subdural hematoma (SDH), but failure rates vary and risk prediction tools are lacking. This study developed and validated a machine learning (ML) model to predict MMAE treatment failure for SDH. METHODS:We conducted an international, multi-institutional retrospective cohort study of patients who underwent MMAE for SDH between 2019 and 2025. The cohort was split into training and test sets, stratified by treatment failure, with all hematomas from each patient assigned to a single cohort to prevent data leakage. Multiple ML algorithms were evaluated using 5-fold cross-validation, with gradient boosting selected as the final model. The primary outcome was treatment failure, defined as rescue surgical evacuation or persistent/recurrent SDH requiring retreatment. Model performance was assessed using area under the curve-receiver operating characteristic. Patients were stratified into low-risk (<5%), medium-risk (5%-15%), and high-risk (>15%) groups using a priori clinically defined thresholds. RESULTS:Among 692 treated hematomas in the test cohort, 64 (9.2%) experienced treatment failure. The gradient boosting model achieved an area under the curve-receiver operating characteristic of 0.856 (95% CI, 0.803-0.902) before calibration and 0.832 (95% CI, 0.766-0.889) after isotonic calibration, with excellent calibration (Brier score, 0.053). The most important predictors were age-platelet interaction, platelet-hemoglobin ratio, platelet count, SDH thickness, and age. Observed treatment failure was 1.6% (95% CI, 0.4%-5.7%) in the low-risk group (n = 124; 17.9%), 6.0% (95% CI, 4.3%-8.4%) in the medium-risk group (n = 516; 74.6%), and 59.6% (95% CI, 46.1%-71.8%) in the high-risk group (n = 52; 7.5%) (P < .001 for trend), a 37.2-fold difference between high- and low-risk groups. CONCLUSION/CONCLUSIONS:This ML model stratified MMAE patients into risk groups with a 37.2-fold difference in treatment failure. High-risk patients had 59.6% failure, whereas low-risk patients had 1.6% failure. Risk stratification may improve patient selection and monitoring.
PMID: 42925034
ISSN: 1524-4040
CID: 6074945

Multi-pedicle versus single-pedicle middle meningeal artery embolization for nonacute subdural hematoma

Thrash, Garrett W; DeMessie, Bluyé; Wang, Elijah L; Jones, Jesse G; Essibayi, Muhammed Amir; Salim, Hamza Adel; Karandish, Alireza; Khatri, Deepak; Haranhalli, Neil; Baker, Amanda; Zampolin, Richard; Brook, Allan L; Lee, Seon-Kyu; Adeeb, Nimer; Lakhani, Dhairya A; Li, Yan-Lin; Simonato, Davide; Ortega, Diego Alejandro; Cancelliere, Nicole; Diestro, Jose Danilo; Carnevale, Joseph; Schreiber, Craig; Orscelik, Atakan; Abecassis, Zachary; Raub, Spencer; Sioutas, Georgios S; Alsalama, Abdulrhman; Pearce, Clairice; Salsano, Giancarlo; Kasem, Rahim Abo; Kvint, Svetlana; Falzon, Andrew; Cantrell, Vance; Holliday, Brian; Abaricia, Jefferson O; Maleknia, Pedram D; Cruz-Criollo, Leonardo; Schimmel, Samantha; Musmar, Basel; Alexander, Matthew; Zermeno, Jorge Rios; Koul, Prateeka; Aljuboori, Ahmed; Vollherbst, Dominik F; Gajski, Domagoj; Cooper, Jared; Alwakaa, Omar; Ezzeldin, Mohamad; Grist, James; Zaccagna, Fulvio; Ogilvy, Christopher S; Al-Mufti, Fawaz; Kalousek, Vladimir; Möhlenbruch, Markus A; Scarcia, Luca; Wroe, William W; Zeineddine, Hussein A; Tang, Si Zhao; Sporns, Peter B; Gopinathan, Anil; Regenhardt, Robert W; Blackburn, Spiros L; Schirmer, Clemens M; Huynh, Thien; Tawk, Rabih G; Settecase, Fabio; Tjoumakaris, Stavropoula; Jabbour, Pascal; Vakharia, Kunal; Zanaty, Mario; Ortega-Gutierrez, Santiago; Colasurdo, Marco; Nasser, Hussein H; Sundararajan, Sri Hari; Mosimann, Pascal J; Nossek, Erez; Raz, Eytan; Kasab, Sami Al; Spiotta, Alejandro M; Castellan, Lucio; Del Sette, Bruno; Alaraj, Ali; Michelozzi, Caterina; Saraceno, Davide; Panni, Pietro; Srinivasan, Visish M; Burkhardt, Jan-Karl; Marnat, Gaultier; Santini, Pietro Mario; Levitt, Michael R; Lanzino, Giuseppe; Brinjikji, Waleed; Knopman, Jared; Kass-Hout, Tareq; Spears, Julian; Marotta, Thomas; Pereira, Vitor Mendes; Fuschi, Maurizio; Patankar, Tufail; Altschul, David J; Dmytriw, Adam A
INTRODUCTION/BACKGROUND:Nonacute subdural hematomas (nSDH) are common yet serious extra-axial hemorrhages that result in significant morbidity and mortality. Middle meningeal artery (MMA) embolization (MMAE) is a recent endovascular treatment that involves occlusion of the MMA, inducing hemostasis in and around the hematoma. While many aspects of MMAE have been explored, there is currently limited data on the optimal extent of embolization. OBJECTIVE:To determine whether single or multiple pedicle embolization of the MMA is superior in inducing hemostasis in nSDH. METHODS:We compared single versus multi pedicle embolization by a retrospective multicenter analysis of nSDH patients who underwent MMAE between 2019 and 2024 at participating centers in the MESH (MMA Embolization for Subdural Hematoma) Registry. 679 patients who received a liquid embolic agent with branch-level embolization data were included. RESULTS:While multi-pedicle embolization hastened nSDH thinning at 1 month (5.7 vs. 3.3 mm reduction; difference 2.4 mm, 95% CI 1.0-3.8; P = .002), by 3 months thickness reduction had converged between groups (8.2 vs. 8.4 mm; P = .91). Among 679 patients (456 multi-pedicle, 223 single-pedicle), favorable functional outcome (mRS 0-2) was more frequent with multi-pedicle embolization (53.5% vs. 43.0%; adjusted OR 1.81, 95% CI 1.26-2.60; P = .001), whereas recurrence, rescue surgery, and treatment failure did not differ. CONCLUSION/CONCLUSIONS:Future, multi-center randomized prospective trials are warranted to address confounding variables that limit this observational study. Follow-up beyond 3 months was limited, so durability is unknown.
PMID: 42766032
ISSN: 1432-1920
CID: 6073501

Factors Associated with Short Hospital Stay After Combined Middle Meningeal Artery Embolization and Surgical Evacuation for Chronic Subdural Hematoma

Terraciano, Anthony; DeMessie, Bluyé; Essibayi, Muhammed Amir; Alsalama, Abdulrhman; Gupta, Khushal; Salim, Hamza Adel; Karandish, Alireza; Adeeb, Nimer; A Lakhani, Dhairya; Li, Yan-Lin; Alejandro Ortega, Diego; Carnevale, Joseph; Orscelik, Atakan; Abecassis, Zachary; Sioutas, Georgios; Salsano, Giancarlo; Abo Kasem, Rahim; Falzon, Andrew; O Abaricia, Jefferson; D Maleknia, Pedram; Cruz-Criollo, Leonardo; Schimmel, Samantha; Musmar, Basel; Alexander, Matthew; Aljuboori, Ahmed; F Vollherbst, Dominik; Gajski, Domagoj; Cooper, Jared; Alwakaa, Omar; Ezzeldin, Mohamad; S Ogilvy, Christopher; Al-Mufti, Fawaz; Kalousek, Vladimir; A Möhlenbruch, Markus; Scarcia, Luca; Si Zhao, Tang; B Sporns, Peter; Gopinathan, Anil; W Regenhardt, Robert; L Blackburn, Spiros; M Schirmer, Clemens; Huynh, Thien; G Tawk, Rabih; Settecase, Fabio; Jabbour, Pascal; Vakharia, Kunal; Zanaty, Mario; Ortega-Gutierrez, Santiago; G Jones, Jesse; Colasurdo, Marco; H Nasser, Hussein; Sundararajan, Sri Hari; J Mosimann, Pascal; Nossek, Erez; Raz, Eytan; M Spiotta, Alejandro; Del Sette, Bruno; Alaraj, Ali; Michelozzi, Caterina; Saraceno, Davide; Panni, Pietro; M Srinivasan, Visish; Burkhardt, Jan-Karl; Marnat, Gaultier; Mario Santini, Pietro; R Levitt, Michael; Lanzino, Giuseppe; Knopman, Jared; Mendes Pereira, Vitor; Patankar, Tufail; A Dmytriw, Adam; J Altschul, David; Collaborators, Mesh
BACKGROUND:Middle meningeal artery embolization (MMAE) plus surgical evacuation is increasingly used for chronic subdural hematoma (cSDH), but predictors of length of stay (LOS) and outcomes associated with early discharge remain unclear. METHODS:We performed a multicenter MESH Registry study (2019-2024) of patients undergoing MMAE and surgical evacuation for symptomatic cSDH. Short-stay discharge was defined as LOS ≤4 days. Predictors were identified using multivariable logistic regression. The 90-day composite adverse event was defined as cSDH recurrence requiring intervention, reintervention (repeat MMAE or surgical evacuation), or 30-day all-cause readmission. Safety was assessed using adjusted logistic regression, generalized estimating equations (GEE), inverse probability of treatment weighting (IPTW), and multiple imputation by chained equations (MICE). RESULTS:Among 647 patients (mean age 72.6 years; 74.0% male), 156 (24.1%) had short-stay discharge. Median LOS was 8 days (IQR 5-15). Older age (aOR 0.76 per 10 years; 95% CI 0.62-0.93; P = 0.008), higher baseline modified Rankin Scale score (aOR 0.79 per point; 95% CI 0.67-0.94; P = 0.007), and greater midline shift (aOR 0.90 per mm; 95% CI 0.85-0.96; P = 0.001) were independently associated with lower odds of short-stay discharge. C‑statistic was 0.683. The 90-day composite event rate was 17.1% in short-stay versus 23.7% in long-stay patients. Short-stay discharge was not significantly associated with the composite outcome on adjusted analysis (aOR 0.56; 95% CI 0.30-1.07; P = 0.08), GEE (aOR 0.61; 95% CI 0.33-1.12; P = 0.11), or MICE (aOR 0.74; 95% CI 0.44-1.25; P = 0.26). IPTW showed a discordant association (OR 0.47; 95% CI 0.24-0.92; P = 0.03). CONCLUSIONS:Older age, worse baseline function, and midline shift were associated with longer hospitalization. Short-stay discharge was not associated with a statistically significant increase in adverse-event rates; however, the study was not powered to establish non-inferiority or safety equivalence, and clinically meaningful differences cannot be excluded.
PMID: 42622854
ISSN: 1869-1447
CID: 6071498

Sonographic Extracranial-Intracranial Bypass Monitoring: Technical Evolution and Current Evidence

Grin, Eric A; Nossek, Erez
Extracranial-intracranial (EC-IC) bypass surgery remains an essential tool in the management of complex cerebrovascular disease, including chronic-ischemic hypoperfused territory as well as intracranial aneurysms requiring parent vessel sacrifice. Reliable postoperative surveillance of graft patency and hemodynamic function is central to long-term success. Sonographic imaging has evolved over four decades from indirect extracranial Doppler waveform analysis through intraoperative microvascular Doppler, quantitative duplex ultrasonography, and transcranial Doppler assessment of intracranial hemodynamics to the contemporary development of trans-sonolucent cranioplasty ultrasonography (TCUS). TCUS, enabled by the replacement of the autologous bone flap with an acoustically transparent polymethyl methacrylate (PMMA) cranioplasty, permits direct, real-time visualization of the anastomosis and surrounding intracranial vasculature. This can be performed at the bedside and in the outpatient setting, without radiation or contrast. Current evidence, drawn largely from small series and early multicenter experience, positions TCUS as a reliable and potentially cost-effective complement to digital subtraction angiography for serial bypass surveillance, though prospective validation remains needed. This review traces the full arc of sonographic bypass monitoring and addresses current evidence, technical considerations, established quantitative parameters, and directions for future investigation.
PMCID:13406802
PMID: 42512447
ISSN: 2076-3425
CID: 6070402

Impact of middle meningeal artery embolization timing on chronic subdural hematoma resolution and functional outcomes

DeMessie, Bluyé; Essibayi, Muhammed Amir; Salim, Hamza Adel; Karandish, Alireza; Farkas, Nathan; Khatri, Deepak; Haranhalli, Neil; Baker, Amanda; Zampolin, Richard; Brook, Allan L; Lee, Seon-Kyu; Adeeb, Nimer; Grist, James; Zaccagna, Fulvio; Li, Yan-Lin; Simonato, Davide; Ortega, Diego Alejandro; Cancelliere, Nicole; Diestro, Jose Danilo; Lakhani, Dhairya A; Carnevale, Joseph; Schreiber, Craig; Orscelik, Atakan; Abecassis, Zachary; Raub, Spencer; Sioutas, Georgios S; Salsano, Giancarlo; Kvint, Svetlana; Falzon, Andrew; Cantrell, Vance; Holliday, Brian; Abaricia, Jefferson O; Maleknia, Pedram D; Cruz-Criollo, Leonardo; Schimmel, Samantha; Musmar, Basel; Alexander, Matthew; Zermeno, Jorge Rios; Prateeka, Koul; Aljuboori, Ahmed; Vollherbst, Dominik F; Gajski, Domagoj; Cooper, Jared; Kasem, Rahim Abo; Kasab, Sami Al; Spiotta, Alejandro M; Al-Mufti, Fawaz; Kalousek, Vladimir; Möhlenbruch, Markus A; Scarcia, Luca; Schirmer, Clemens M; Huynh, Thien; Tawk, Rabih G; Settecase, Fabio; Tjoumakaris, Stavropoula; Jabbour, Pascal; Vakharia, Kunal; Zanaty, Mario; Ortega-Gutierrez, Santiago; Jones, Jesse G; Colasurdo, Marco; Nasser, Hussein H; Sundararajan, Sri Hari; Mosimann, Pascal J; Nossek, Erez; Raz, Eytan; Castellan, Lucio; Sette, Bruno Del; Michelozzi, Caterina; Saraceno, Davide; Panni, Pietro; Srinivasan, Visish; Burkhardt, Jan-Karl; Marnat, Gaultier; Santini, Pietro Mario; Levitt, Michael R; Lanzino, Giuseppe; Brinjikji, Waleed; Knopman, Jared; Kass-Hout, Tareq; Spears, Julian; Marotta, Thomas; Wintermark, Max; Pereira, Vitor Mendes; Fuschi, Maurizio; Dmytriw, Adam A; Altschul, David J; ,
BACKGROUND AND PURPOSE/OBJECTIVE:Chronic subdural hematoma (cSDH) affects approximately 20 per 100,000 individuals annually, with surgical recurrence rates of 10-20%. Middle meningeal artery embolization (MMAE) has emerged as a promising minimally invasive treatment, but the optimal timing remains unclear. We evaluated the association between MMAE timing and radiological and functional outcomes in cSDH. METHODS:We conducted a retrospective multicenter international cohort study across 33 centres, including patients who underwent MMAE for cSDH between January 2018 and December 2024. Patients were stratified by timing from diagnosis: Q1 (≤1 day), Q2 (2 days), Q3 (3-6 days), and Q4 (>6 days). The primary composite endpoint required radiological success (hematoma thickness <5 mm at 1-3 months), absence of emergency surgical evacuation, and either functional improvement or good functional outcome (modified Rankin Scale 0-2). Propensity score matching compared Q1 and Q4. RESULTS:Of 1,781 patients screened, 908 met inclusion criteria. Mean age was 73.7 ± 12.2 years, and 70.9% were female. Early embolization (Q1) achieved the primary composite endpoint more frequently than delayed embolization (Q4), with concordant improvements in radiological and functional components and no difference in rescue surgery. Good functional outcome was achieved in 76.0% of Q1 patients versus 63.8% in Q4 (absolute difference, 12.2%; P=.003; number needed to treat approximately 8). Hospital length of stay was 21.0 days shorter in Q1 versus Q4 (P<.001), partly attributable to the timing definition. In 174 propensity score-matched pairs, early embolization was associated with higher odds of achieving the primary endpoint (odds ratio, 6.41; 95% confidence interval, 3.29-12.48; P<.001), with pronounced benefit among patients receiving antithrombotic therapy (odds ratio, 8.06; 95% confidence interval, 3.65-17.80). CONCLUSIONS:Early MMAE (≤1 day from diagnosis) was overall associated with better outcomes compared with delayed intervention, particularly among patients receiving antithrombotic therapy. Prospective confirmation is warranted.
PMID: 42431081
ISSN: 0150-9861
CID: 6064342

Dynamic Angiography Demonstrating Discogenic Bow Hunter Syndrome

Sharashidze, Vera; Shapiro, Maksim; Nossek, Erez; Ruffino, Luca; Raz, Eytan
PMID: 42330130
ISSN: 1524-4628
CID: 6055332

Real-World Safety Profile of Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: a Multinational Multicenter Study

DeMessie, Bluyé; Karandish, Alireza; Essibayi, Muhammed Amir; Salim, Hamza Adel; Khatri, Deepak; Haranhalli, Neil; Baker, Amanda; Zampolin, Richard; Brook, Allan L; Lee, Seon-Kyu; Adeeb, Nimer; Lakhani, Dhairya A; Li, Yan-Lin; Ortega, Diego Alejandro; Cancelliere, Nicole; Diestro, Jose Danilo; Carnevale, Joseph; Schreiber, Craig; Orscelik, Atakan; Abecassis, Zachary; Raub, Spencer; Sioutas, Georgios S; Alsalama, Abdulrhman; Pearce, Clairice; Salsano, Giancarlo; Abo Kasem, Rahim; Kvint, Svetlana; Falzon, Andrew; Cantrell, Vance; Holliday, Brian; Abaricia, Jefferson O; Maleknia, Pedram; Cruz-Criollo, Leonardo; Schimmel, Samantha; Musmar, Basel; Alexander, Matthew; Zermeno, Jorge Rios; Prateeka, Koul; Aljuboori, Ahmed; Vollherbst, Dominik F; Gajski, Domagoj; Cooper, Jared; Alwakaa, Omar; Ezzeldin, Mohamad; Grist, James; Zaccagna, Fulvio; Ogilvy, Christopher S; Al-Mufti, Fawaz; Kalousek, Vladimir; Möhlenbruch, Markus A; Scarcia, Luca; Wroe, William W; Zeineddine, Hussein A; Si Zhao, Tang; Sporns, Peter B; Gopinathan, Anil; Regenhardt, Robert W; Blackburn, Spiros L; Schirmer, Clemens M; Huynh, Thien; Tawk, Rabih; Settecase, Fabio; Tjoumakaris, Stavropoula; Jabbour, Pascal; Vakharia, Kunal; Zanaty, Mario; Ortega-Gutierrez, Santiago; Jones, Jesse G; Colasurdo, Marco; Nasser, Hussein H; Sundararajan, Sri Hari; Mosimann, Pascal J; Nossek, Erez; Raz, Eytan; Al Kasab, Sami; Spiotta, Alejandro M; Castellan, Lucio; Del Sette, Bruno; Alaraj, Ali; Michelozzi, Caterina; Saraceno, Davide; Panni, Pietro; Srinivasan, Visish M; Burkhardt, Jan-Karl; Marnat, Gaultier; Santini, Pietro Mario; Levitt, Michael R; Lanzino, Giuseppe; Knopman, Jared; Kass-Hout, Tareq; Spears, Julian; Marotta, Thomas; Mendes Pereira, Vitor; Patankar, Tufail; Dmytriw, Adam A; Altschul, David J
BACKGROUND:Middle meningeal artery embolization (MMAE) has emerged as a treatment for chronic subdural hematoma (cSDH), but comprehensive real-world safety data remain limited. METHODS:We performed a multicenter retrospective analysis of 1781 consecutive patients undergoing MMAE for cSDH (2019-2025). The primary outcome was any procedure-related complication within 30 days. Inverse probability of treatment weighting (IPTW) assessed the association between technical success and complications, adjusting for demographic, clinical, and procedural confounders. RESULTS:Mean age was 72.8 ± 12.4 years; 68.1% were male. The 30-day complication rate was 5.1% (91/1781; 95% CI, 4.1-6.2). In-hospital mortality was 2.9% (47/1625). Technical success was achieved in 97.5% (1505/1543). Among documented complications, thromboembolic events were most common (37.2%; 32/86), followed by hemorrhagic complications (23.8%; 20/84) and access-site hematoma (10.4%; 8/77). Among patients with classifiable symptom status, 80.6% of complications were symptomatic, yielding an overall symptomatic complication rate of 3.0%. Neurological deterioration occurred in 27.1% (248/915). Among 1552 patients with documented surgical approach, complication rates were similar between surgery plus embolization (4.9%; 34/690) and embolization alone (5.2%; 45/860; OR, 0.94; 95% CI, 0.59-1.48; p = 0.79). After IPTW adjustment, technical success was associated with an 86% reduction in complication odds (OR, 0.14; 95% CI, 0.05-0.40; p < 0.001). CONCLUSIONS:In this large multicenter cohort, MMAE was associated with a 5.1% complication rate. Technical success was the strongest protective factor. Embolization with or without surgery showed equivalent safety profiles.
PMID: 42274749
ISSN: 1869-1447
CID: 6048662

Temporal relationship between hematoma resolution and functional recovery after middle meningeal artery embolization for chronic subdural hematoma

DeMessie, Bluyé; Essibayi, Muhammed Amir; Salim, Hamza Adel; Karandish, Alireza; Park, Jaewoo; Khatri, Deepak; Haranhalli, Neil; Baker, Amanda; Zampolin, Richard; Brook, Allan L; Lee, Seon-Kyu; Adeeb, Nimer; Li, Yan-Lin; Simonato, Davide; Ortega, Diego Alejandro; Cancelliere, Nicole; Diestro, Jose Danilo; Carnevale, Joseph A; Schreiber, Craig; Orscelik, Atakan; Abecassis, Zachary; Raub, Spencer; Sioutas, Georgios S; Salsano, Giancarlo; Abo Kasem, Rahim; Kvint, Svetlana; Falzon, Andrew; Cantrell, Vance; Holliday, Brian; Abaricia, Jefferson O; Maleknia, Pedram D; Cruz-Criollo, Leonardo; Schimmel, Samantha; Musmar, Basel; Alexander, Matthew D; Rios Zermeno, Jorge; Koul, Prateeka; Aljuboori, Ahmed; Vollherbst, Dominik F; Gajski, Domagoj; Cooper, Jared; Alwakaa, Omar; Ogilvy, Christopher S; Al-Mufti, Fawaz; Kalousek, Vladimir; Möhlenbruch, Markus A; Scarcia, Luca; Schirmer, Clemens M; Huynh, Thien; Tawk, Rabih G; Settecase, Fabio; Tjoumakaris, Stavropoula; Jabbour, Pascal; Vakharia, Kunal; Zanaty, Mario; Ortega-Gutierrez, Santiago; Jones, Jesse G; Colasurdo, Marco; Nasser, Hussein H; Sundararajan, Sri Hari; Mosimann, Pascal J; Nossek, Erez; Raz, Eytan; Al Kasab, Sami; Spiotta, Alejandro M; Castellan, Lucio; Del Sette, Bruno; Michelozzi, Caterina; Saraceno, Davide; Panni, Pietro; Srinivasan, Visish M; Burkhardt, Jan-Karl; Marnat, Gaultier; Santini, Pietro Mario; Levitt, Michael R; Lanzino, Giuseppe; Brinjikji, Waleed; Knopman, Jared; Kass-Hout, Tareq; Spears, Julian; Marotta, Thomas; Mendes Pereira, Vitor; Fuschi, Maurizio; Dmytriw, Adam A; Altschul, David J; ,
OBJECTIVE:The objective was to evaluate the trajectories of hematoma resolution and functional improvement after middle meningeal artery embolization (MMAE) for chronic subdural hematoma (cSDH), model the temporal pattern of cSDH resolution, and identify factors associated with favorable outcomes. METHODS:This real-world multicenter retrospective study included cSDH patients treated with MMAE at 24 centers between 2019 and 2024. Hematoma thickness was measured at baseline and at follow-up intervals (1-4 weeks, 1-3 months, 3-6 months, 6-12 months, and > 12 months after embolization). Resolution patterns were modeled using exponential decay functions. Modified Rankin Scale (mRS) scores assessed functional outcomes. Good functional outcome was defined as mRS score ≤ 2. Resolution patterns were modeled using exponential decay functions to estimate time to 50% and 80% reduction. Patients were categorized as complete resolution (≥ 99%) or by quartile of the remaining distribution (substantial [73%-98%], moderate [53%-73%], partial [27%-53%], minimal [< 27%]). The primary outcome was good functional status (mRS score ≤ 2). RESULTS:The authors analyzed a total of 1781 patients with 2295 cSDHs who underwent MMAE. The mean ± SD age was 72.8 ± 12.4 years and 68.1% of patients were male. The initial mean hematoma thickness was 15.31 ± 6.53 mm, decreasing to 5.24 ± 5.91 mm at final follow-up (mean reduction 64.3% ± 42.1%). Resolution followed an exponential decay pattern, with an estimated time to 50% reduction of 1.8 months and to 80% reduction of 8.9 months. Complete resolution occurred in 1031 of 2224 patients (46.4%) with complete follow-up. The median (IQR) mRS score improved from 1 (0-3) at baseline to 0 (0-2) at > 12 months. Good functional outcomes were more common in patients with complete versus minimal resolution (68.9% vs 35.0%, p < 0.001). Achieving ≥ 73% resolution within 90 days was associated with better outcomes (good outcome in 76.9% of those with ≥ 73% resolution vs 67.3% in those without, p < 0.001). Neurological deterioration was the strongest predictor of lack of good outcome (23.7% in patients with neurological deterioration vs 82.4% without, p < 0.001). CONCLUSIONS:After MMAE for cSDH, reduction in hematoma thickness follows a predictable exponential decay pattern. Greater extent (≥ 80%) and faster timing (within 90 days) of resolution are valuable prognostic indicators. Functional outcomes improve progressively through 6-12 months after the procedure. The relationship between resolution extent and functional outcomes provides quantitative benchmarks for evaluating treatment response.
PMID: 42172679
ISSN: 1933-0693
CID: 6038792